HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Spitzweg Selected Research

Iodides

2/2008Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
11/2006Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
1/2006Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
2/2005Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
3/2004Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
8/2003Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
4/2003[The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
1/2001Approaches to gene therapy with sodium/iodide symporter.
11/2000Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Spitzweg Research Topics

Disease

13Neoplasms (Cancer)
05/2024 - 01/2001
6Prostatic Neoplasms (Prostate Cancer)
03/2004 - 11/2000
5Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2024 - 02/2012
4Thyroid Diseases (Thyroid Disease)
05/2010 - 06/2000
3Hypothyroidism
01/2018 - 10/2014
3Hepatocellular Carcinoma (Hepatoma)
06/2013 - 02/2008
2Neoplasm Metastasis (Metastasis)
05/2024 - 02/2012
2Thyrotoxicosis
10/2017 - 10/2014
2Hyperthyroidism
10/2017 - 05/2010
2Thyroiditis
10/2014 - 06/2000
2Breast Neoplasms (Breast Cancer)
11/2006 - 01/2006
2Thyroid Neoplasms (Thyroid Cancer)
11/2006 - 10/2001
2Adenocarcinoma
08/2003 - 11/2000
1Disease Progression
08/2019
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
01/2018
1Coma (Comas)
10/2017
1Thyroid Crisis (Thyrotoxic Crisis)
10/2017
1Hypercapnia
10/2017
1Hyponatremia
10/2017
1Hypothermia
10/2017
1Hypoventilation
10/2017
1Myxedema
10/2017
1Pneumonia (Pneumonitis)
10/2017
1Spontaneous Abortion (Miscarriage)
10/2014
1Liver Neoplasms (Liver Cancer)
06/2013
1Cushing Syndrome
02/2012
1Ectopic ACTH Syndrome
02/2012
1Glioblastoma (Glioblastoma Multiforme)
12/2011
1Isolated Systolic Hypertension
05/2010
1medullary Thyroid cancer
06/2009
1Fibroadenoma
11/2006
1Papillary Thyroid Cancer
11/2006
1Colonic Neoplasms (Colon Cancer)
02/2005
1Carcinoma (Carcinomatosis)
02/2005
1Graves Disease (Basedow Disease)
06/2000
1Graves Ophthalmopathy
02/2000

Drug/Important Bio-Agent (IBA)

13sodium-iodide symporter (sodium iodide symporter)IBA
01/2021 - 06/2000
9IodidesIBA
02/2008 - 11/2000
4Somatostatin Receptors (Somatostatin Receptor)IBA
05/2024 - 02/2012
4Thyroid HormonesIBA
01/2018 - 05/2010
4Therapeutic UsesIBA
06/2013 - 11/2000
3Prostate-Specific Antigen (Semenogelase)IBA
03/2004 - 11/2000
2Radioisotopes (Radionuclides)IBA
01/2021 - 02/2012
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020 - 02/2012
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018 - 10/2014
2AntibodiesIBA
10/2014 - 06/2000
2Proteins (Proteins, Gene)FDA Link
02/2008 - 03/2004
2Complementary DNA (cDNA)IBA
02/2008 - 11/2000
2Messenger RNA (mRNA)IBA
02/2008 - 03/2004
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006 - 08/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2006 - 03/2004
2AndrogensIBA
03/2004 - 08/2003
1Contrast MediaIBA
05/2024
1lutetium Lu 177 dotatateIBA
08/2019
1177Lu-DOTA-octreotateIBA
08/2019
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2018
1GlucocorticoidsIBA
10/2017
1perchlorateIBA
10/2017
1Lugol's solution (Lugol's iodine)IBA
10/2017
1Cholestyramine Resin (Questran)FDA LinkGeneric
10/2017
1Antithyroid Agents (Antithyroid Drugs)IBA
10/2017
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
10/2014
1Peptide Receptors (Peptide Receptor)IBA
02/2012
1Interferon-alpha (Interferon Alfa)IBA
02/2012
1Dopamine Agonists (Dopamine Agonist)IBA
02/2012
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2012
1Adrenocorticotropic Hormone (ACTH)FDA Link
02/2012
1CabergolineFDA LinkGeneric
02/2012
1ErbB Receptors (EGF Receptor)IBA
12/2011
1Peptides (Polypeptides)IBA
12/2011
1Adrenergic Agents (Adrenergic Drugs)IBA
05/2010
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2008
1ParaffinIBA
11/2006
1Estrogen ReceptorsIBA
01/2006
1Carcinoembryonic AntigenIBA
02/2005
1Indicators and Reagents (Reagents)IBA
10/2001
1CytokinesIBA
06/2000
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2000
1Interleukin-1 (Interleukin 1)IBA
02/2000

Therapy/Procedure

17Therapeutics
08/2019 - 11/2000
1Precision Medicine
01/2021
1Salvage Therapy
08/2019
1Critical Care (Surgical Intensive Care)
10/2017
1Thyroidectomy
10/2017
1Gamma Cameras (Gamma Camera)
06/2013
1Oncolytic Virotherapy
06/2013
1Biological Therapy
02/2012
1Palliative Care (Palliative Therapy)
02/2012
1Radiotherapy
10/2001